New mRNA flu shots enter human testing – could they beat the seasonal bug?
NCT ID NCT07204964
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 33 times
Summary
This study tests new mRNA-based flu vaccines in about 971 healthy adults aged 18 and older. The goal is to see if these vaccines are safe and trigger a strong immune response against seasonal flu. Participants receive the vaccine and are monitored for side effects and antibody levels. This is a phase 2a trial, meaning it's still early but building toward larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Guntersville, Alabama, 35976, United States
-
GSK Investigational Site
Canoga Park, California, 91303, United States
-
GSK Investigational Site
Walnut Creek, California, 94598, United States
-
GSK Investigational Site
Hialeah, Florida, 33012, United States
-
GSK Investigational Site
Miami, Florida, 33186, United States
-
GSK Investigational Site
Pembroke Pines, Florida, 33025, United States
-
GSK Investigational Site
Stockbridge, Georgia, 30281, United States
-
GSK Investigational Site
Carson City, Nevada, 89706, United States
-
GSK Investigational Site
Las Vegas, Nevada, 89109, United States
-
GSK Investigational Site
Greensboro, North Carolina, 27408, United States
-
GSK Investigational Site
North Charleston, South Carolina, 29405, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
Garland, Texas, 75043, United States
-
GSK Investigational Site
Newport News, Virginia, 23606, United States
-
GSK Investigational Site
Seattle, Washington, 98104, United States
-
GSK Investigational Site
Edegem, 2650, Belgium
-
GSK Investigational Site
Ghent, 9000, Belgium
Conditions
Explore the condition pages connected to this study.